Works matching IS 10538569 AND DT 2015 AND VI 24 AND IP 12
Results: 14
The potential drug-drug interaction between proton pump inhibitors and warfarin.
- Published in:
- 2015
- By:
- Publication type:
- Other
Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1271, doi. 10.1002/pds.3882
- By:
- Publication type:
- Article
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1321, doi. 10.1002/pds.3883
- By:
- Publication type:
- Article
Ticagrelor and bradycardia: a nested case-control study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1281, doi. 10.1002/pds.3884
- By:
- Publication type:
- Article
Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1304, doi. 10.1002/pds.3885
- By:
- Publication type:
- Article
The adherence-outcome relationship is not altered by diary-driven adjustments of microelectronic monitor data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1313, doi. 10.1002/pds.3887
- By:
- Publication type:
- Article
Erratum: Using claims data to predict dependency in activities of daily living as a proxy for frailty.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1341, doi. 10.1002/pds.3888
- Publication type:
- Article
Use of macrolides during pregnancy and the risk of birth defects: a population-based study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1241, doi. 10.1002/pds.3900
- By:
- Publication type:
- Article
Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis?
- Published in:
- 2015
- By:
- Publication type:
- Other
Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1233, doi. 10.1002/pds.3859
- By:
- Publication type:
- Article
Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1259, doi. 10.1002/pds.3874
- By:
- Publication type:
- Article
Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication use.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1286, doi. 10.1002/pds.3876
- By:
- Publication type:
- Article
Do CHA<sub>2</sub>DS<sub>2</sub>VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1297, doi. 10.1002/pds.3878
- By:
- Publication type:
- Article
Relationship between calcium channel blocker class and mortality in dialysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 12, p. 1249, doi. 10.1002/pds.3869
- By:
- Publication type:
- Article